List of Excipients in API ENTACAPONE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ENTACAPONE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | COMTAN | entacapone | 0078-0327 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | COMTAN | entacapone | 0078-0327 | CROSCARMELLOSE SODIUM | |
| Novartis Pharmaceuticals Corporation | COMTAN | entacapone | 0078-0327 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | COMTAN | entacapone | 0078-0327 | FERRIC OXIDE YELLOW | |
| Novartis Pharmaceuticals Corporation | COMTAN | entacapone | 0078-0327 | GLYCERIN | |
| Novartis Pharmaceuticals Corporation | COMTAN | entacapone | 0078-0327 | HYDROGENATED COTTONSEED OIL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ENTACAPONE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 | CELLULOSE, MICROCRYSTALLINE |
| Lannett Company Inc | entacapone | 0527-1830 | FERRIC OXIDE RED |
| Lannett Company Inc | entacapone | 0527-1830 | FERRIC OXIDE YELLOW |
| Lannett Company Inc | entacapone | 0527-1830 | LECITHIN, SOYBEAN |
| Lannett Company Inc | entacapone | 0527-1830 | MAGNESIUM STEARATE |
| Lannett Company Inc | entacapone | 0527-1830 | MANNITOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ENTACAPONE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ENTACAPONE drug variants containing CELLULOSE, MICROCRYSTALLINE
ENTACAPONE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ENTACAPONE drug variants containing CROSCARMELLOSE SODIUM
ENTACAPONE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
ENTACAPONE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | entacapone | 55648-711 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C YELLOW NO. 6
ENTACAPONE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | entacapone | 55648-711 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
ENTACAPONE drug variants containing FERRIC OXIDE RED
ENTACAPONE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | entacapone | 55648-711 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ENTACAPONE drug variants containing FERRIC OXIDE YELLOW
ENTACAPONE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | entacapone | 55648-711 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
ENTACAPONE drug variants containing GLYCERIN
ENTACAPONE drug variants not containing GLYCERIN
Excipient focus: HYDROGENATED COTTONSEED OIL
ENTACAPONE drug variants containing HYDROGENATED COTTONSEED OIL
ENTACAPONE drug variants not containing HYDROGENATED COTTONSEED OIL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| NCS HealthCare of KY Inc dba Vangard Labs | entacapone | 0615-8298 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| Macleods Pharmaceuticals Limited | entacapone | 33342-260 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ENTACAPONE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | entacapone | 0078-0327 |
| Mylan Pharmaceuticals Inc | entacapone | 0378-9080 |
| Sandoz Inc | entacapone | 0781-5578 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| Alembic Pharmaceuticals Limited | entacapone | 46708-478 |
| Mylan Institutional Inc | entacapone | 51079-273 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
ENTACAPONE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | entacapone | 0904-6822 |
| Aphena Pharma Solutions - Tennessee LLC | entacapone | 43353-996 |
| AvPAK | entacapone | 50268-295 |
| Wockhardt Limited | entacapone | 55648-711 |
| American Health Packaging | entacapone | 60687-188 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
ENTACAPONE drug variants containing HYPROMELLOSES
ENTACAPONE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | entacapone | 0078-0327 |
| Mylan Pharmaceuticals Inc | entacapone | 0378-9080 |
| Lannett Company Inc | entacapone | 0527-1830 |
| Sandoz Inc | entacapone | 0781-5578 |
| Major Pharmaceuticals | entacapone | 0904-6822 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ENTACAPONE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | entacapone | 0904-6822 |
| AvPAK | entacapone | 50268-295 |
| American Health Packaging | entacapone | 60687-188 |
| Aurobindo Pharma Limited | entacapone | 65862-654 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
ENTACAPONE drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
ENTACAPONE drug variants containing MAGNESIUM STEARATE
ENTACAPONE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
ENTACAPONE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | entacapone | 0078-0327 |
| Mylan Pharmaceuticals Inc | entacapone | 0378-9080 |
| Lannett Company Inc | entacapone | 0527-1830 |
| Sandoz Inc | entacapone | 0781-5578 |
| Major Pharmaceuticals | entacapone | 0904-6822 |
| Aphena Pharma Solutions - Tennessee LLC | entacapone | 43353-996 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | entacapone | 0615-8298 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| Macleods Pharmaceuticals Limited | entacapone | 33342-260 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ENTACAPONE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 4000
ENTACAPONE drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
ENTACAPONE drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
Excipient focus: POLYSORBATE 80
ENTACAPONE drug variants containing POLYSORBATE 80
ENTACAPONE drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
ENTACAPONE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
ENTACAPONE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| NCS HealthCare of KY Inc dba Vangard Labs | entacapone | 0615-8298 |
| Macleods Pharmaceuticals Limited | entacapone | 33342-260 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
ENTACAPONE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | entacapone | 0615-8298 |
| Macleods Pharmaceuticals Limited | entacapone | 33342-260 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | entacapone | 0078-0327 |
| Mylan Pharmaceuticals Inc | entacapone | 0378-9080 |
| Lannett Company Inc | entacapone | 0527-1830 |
| Sandoz Inc | entacapone | 0781-5578 |
| Major Pharmaceuticals | entacapone | 0904-6822 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ENTACAPONE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | entacapone | 46708-478 |
| Wockhardt Limited | entacapone | 55648-711 |
| Alembic Pharmaceuticals Inc | entacapone | 62332-478 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ENTACAPONE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | entacapone | 0904-6822 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| AvPAK | entacapone | 50268-295 |
| Wockhardt Limited | entacapone | 55648-711 |
| American Health Packaging | entacapone | 60687-188 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
ENTACAPONE drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | entacapone | 0527-1830 |
| Sunshine Lake Pharma Co Ltd | entacapone | 48792-7830 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: STARCH, CORN
ENTACAPONE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | entacapone | 0615-8298 |
| Macleods Pharmaceuticals Limited | entacapone | 33342-260 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | entacapone | 0078-0327 |
| Mylan Pharmaceuticals Inc | entacapone | 0378-9080 |
| Lannett Company Inc | entacapone | 0527-1830 |
| Sandoz Inc | entacapone | 0781-5578 |
| Major Pharmaceuticals | entacapone | 0904-6822 |
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
ENTACAPONE drug variants containing SUCROSE
ENTACAPONE drug variants not containing SUCROSE
Excipient focus: TALC
ENTACAPONE drug variants containing TALC
ENTACAPONE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ENTACAPONE drug variants containing TITANIUM DIOXIDE
ENTACAPONE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ENTACAPONE drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | entacapone | 55648-711 |
| Wockhardt USA LLC | entacapone | 64679-711 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing TRIACETIN
Excipient focus: WATER
ENTACAPONE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | entacapone | 27241-049 |
| >Company | >Ingredient | >NDC |
ENTACAPONE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
